128 related articles for article (PubMed ID: 15621575)
1. Insulin-like growth factor-1 (IGF-1)-derived peptide protects against diabetes in NOD mice.
Kodama K; Shimada A; Funae O; Morimoto J; Irie J; Shigihara T; Oikawa Y; Tokui M; Watanabe K; Saruta T
Autoimmunity; 2004; 37(6-7):481-7. PubMed ID: 15621575
[TBL] [Abstract][Full Text] [Related]
2. Regulatory Th2-type T cell lines against insulin and GAD peptides derived from orally- and nasally-treated NOD mice suppress diabetes.
Maron R; Melican NS; Weiner HL
J Autoimmun; 1999 Jun; 12(4):251-8. PubMed ID: 10330296
[TBL] [Abstract][Full Text] [Related]
3. [Recombinant human IGF-1 prevents type 1 diabetes in female non-obese diabetic mice].
Liu F; Yu M; Zhu Q
Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Sep; 34(5):281-3. PubMed ID: 11372396
[TBL] [Abstract][Full Text] [Related]
4. T cells with multiple fine specificities are used by non-obese diabetic (NOD) mice in the response to GAD(524-543).
Quinn A; Sercarz EE
J Autoimmun; 1996 Jun; 9(3):365-70. PubMed ID: 8816972
[TBL] [Abstract][Full Text] [Related]
5. Effects of insulin like growth factor-1 and insulin on effector T cells generating autoimmune diabetes.
Bergerot I; Fabien N; Thivolet C
Diabetes Metab; 1996 Jul; 22(4):235-9. PubMed ID: 8767168
[TBL] [Abstract][Full Text] [Related]
6. Endogenous immune response to glutamic acid decarboxylase (GAD67) in NOD mice is modulated by adjuvant immunotherapy.
Qin HY; Elliott JF; Lakey JR; Rajotte RV; Singh B
J Autoimmun; 1998 Dec; 11(6):591-601. PubMed ID: 9878081
[TBL] [Abstract][Full Text] [Related]
7. Suppression of type 1 diabetes in NOD mice by bifunctional peptide inhibitor: modulation of the immunological synapse formation.
Murray JS; Oney S; Page JE; Kratochvil-Stava A; Hu Y; Makagiansar IT; Brown JC; Kobayashi N; Siahaan TJ
Chem Biol Drug Des; 2007 Sep; 70(3):227-36. PubMed ID: 17718717
[TBL] [Abstract][Full Text] [Related]
8. Immunization of diabetes-prone or non-diabetes-prone mice with GAD65 does not induce diabetes or islet cell pathology.
Plesner A; Worsaae A; Dyrberg T; Gotfredsen C; Michelsen BK; Petersen JS
J Autoimmun; 1998 Aug; 11(4):335-41. PubMed ID: 9776711
[TBL] [Abstract][Full Text] [Related]
9. Antigen based therapies to prevent diabetes in NOD mice.
Ramiya VK; Shang XZ; Pharis PG; Wasserfall CH; Stabler TV; Muir AB; Schatz DA; Maclaren NK
J Autoimmun; 1996 Jun; 9(3):349-56. PubMed ID: 8816970
[TBL] [Abstract][Full Text] [Related]
10. Incomplete Freund's adjuvant reduces diabetes in the non-obese diabetic mouse.
Liddi R; Beales PE; Rosignoli G; Pozzilli P
Horm Metab Res; 2000 Jun; 32(6):201-6. PubMed ID: 10898548
[TBL] [Abstract][Full Text] [Related]
11. [Inhibition of islet beta cell apoptosis and prevention diabetes by subcutaneous administration of insulin in NOD mice].
Jiang TJ; Zhou ZG; Su H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Aug; 31(4):499-504. PubMed ID: 16951506
[TBL] [Abstract][Full Text] [Related]
12. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
[TBL] [Abstract][Full Text] [Related]
13. Protection from insulin dependent diabetes mellitus afforded by insulin antigens in incomplete Freund's adjuvant depends on route of administration.
Hutchings P; Cooke A
J Autoimmun; 1998 Apr; 11(2):127-30. PubMed ID: 9650091
[TBL] [Abstract][Full Text] [Related]
14. Treatment of NOD diabetes with a novel peptide of the hsp60 molecule induces Th2-type antibodies.
Bockova J; Elias D; Cohen IR
J Autoimmun; 1997 Aug; 10(4):323-9. PubMed ID: 9237795
[TBL] [Abstract][Full Text] [Related]
15. [Liposome and complete Freund's adjuvant for the prevention of insulitis in non-obese diabetic mice].
Su H; Jiang TJ; Zhou ZG
Hunan Yi Ke Da Xue Xue Bao; 2002 Feb; 27(1):32-4. PubMed ID: 12575229
[TBL] [Abstract][Full Text] [Related]
16. CD8+ T lymphocytes specific for glutamic acid decarboxylase 90-98 epitope mediate diabetes in NOD SCID mouse.
Sévère S; Gauvrit A; Vu AT; Bach JM
Mol Immunol; 2007 Apr; 44(11):2950-60. PubMed ID: 17336387
[TBL] [Abstract][Full Text] [Related]
17. [Mechanisms of human glutamic acid decarboxylase 65 DNA vaccine preventing diabetes in non-obese diabetic mice].
Luo JH; Zhou ZG; Jiang TJ; Pei JH; Li X; He L; Sun SG
Zhonghua Yi Xue Za Zhi; 2004 Nov; 84(21):1791-5. PubMed ID: 15631776
[TBL] [Abstract][Full Text] [Related]
18. Peptide-pulsed immature dendritic cells reduce response to beta cell target antigens and protect NOD recipients from type I diabetes.
Lo J; Peng RH; Barker T; Xia CQ; Clare-Salzler MJ
Ann N Y Acad Sci; 2006 Oct; 1079():153-6. PubMed ID: 17130547
[TBL] [Abstract][Full Text] [Related]
19. [Effects of pravastatin in prevention of diabetes and mechanism thereof: experiment with non-obese diabetic mice].
Zhang S; Yan X; Zhou PC; Huang C; Yang L; Li X; Lin J; Zhou ZG
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(8):568-72. PubMed ID: 18649776
[TBL] [Abstract][Full Text] [Related]
20. The natural history of insulin content in the pancreas of female and male non-obese diabetic mouse: implications for trials of diabetes prevention in humans.
Valorani MG; Hawa MI; Buckley LR; Afeltra A; Cacciapaglia F; Pozzilli P
Diabetes Metab Res Rev; 2004; 20(5):394-8. PubMed ID: 15343585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
